title: Recovery from major depression. A 10-year prospective follow-up across multiple episodes.
abstract: BACKGROUND
  Major depressive disorder is often marked by repeated episodes of depression. We describe recovery from major depression across multiple mood episodes in patients with unipolar major depression at intake and examine the association of sociodemographic and clinical variables with duration of illness.
  
  
  METHODS
  A cohort of 258 subjects treated for unipolar major depressive disorder was followed up prospectively for 10 years as part of the Collaborative Depression Study, a multicenter naturalistic study of the mood disorders. Diagnoses were made according to the Research Diagnostic Criteria, and the course of illness was assessed with the Longitudinal Interval Follow-up Evaluation. Survival analyses were used to calculate the duration of illness for the first 5 recurrent mood episodes after recovery from the index episode.
  
  
  RESULTS
  Diagnosis remained unipolar major depressive disorder for 235 subjects (91%). The median duration of illness was 22 weeks for the first recurrent mood episode, 20 weeks for the second, 21 weeks for the third, and 19 weeks for the fourth and fifth recurrent mood episodes; the 95% confidence intervals were highly consistent. From one episode to the next, the proportion of subjects who recovered by any one time point was similar. For subjects with 2 or more recoveries, the consistency of duration of illness from one recovery to the next was low to moderate. None of the sociodemographic or clinical variables consistently predicted duration of illness.
  
  
  CONCLUSIONS
  In this sample of patients treated at tertiary care centers for major depressive disorder, the duration of recurrent mood episodes was relatively uniform and averaged approximately 20 weeks.
authors.affiliation: Department of Psychiatry and Human Behavior, Brown University, Providence, RI, USA.
authors.forename: D A
authors.initials: DA
authors.lastname: Solomon
authors.forename: M B
authors.initials: MB
authors.lastname: Keller
authors.forename: A C
authors.initials: AC
authors.lastname: Leon
authors.forename: T I
authors.initials: TI
authors.lastname: Mueller
authors.forename: M T
authors.initials: MT
authors.lastname: Shea
authors.forename: M
authors.initials: M
authors.lastname: Warshaw
authors.forename: J D
authors.initials: JD
authors.lastname: Maser
authors.forename: W
authors.initials: W
authors.lastname: Coryell
authors.forename: J
authors.initials: J
authors.lastname: Endicott
mesh_terms: D000328:Adult; D003131:Combined Modality Therapy; D003866:Depressive Disorder / Q000175:diagnosis* / Q000523:psychology / Q000628:therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008297:Male; D017533:Marital Status; D011446:Prospective Studies; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data; D011613:Psychotherapy; D012008:Recurrence; D012720:Severity of Illness Index; D012923:Social Class; D016019:Survival Analysis
chemical_list: D007099:Imipramine